Having had three or four shots of the same vaccine at the same time is up to date. The current boosters are based on the original strain of the coronaviruses that emerged in late 2019. They are still protecting against deaths and hospitalizations.
The world needs a long-term boosting strategy because of the decline in immunity and the emergence of more infectious diseases.
I study immunity to Viruses. I was part of the team that helped develop the Moderna and Johnson & Johnson vaccine.
I think people are likely to need a booster shot in the future. No one has a crystal ball to see which variant of the vaccine will be the best. It's possible to suggest what the future could look like if you look at other respiratory viral foes.
One example is provided by the flu. It's endemic in humans, meaning it still causes seasonal waves of infections in the population. Every year officials try to figure out the best way to give a flu shot.
It is possible that people will need booster shots in the future due to the evolution of the disease. I think scientists will need to update the vaccine in the future to take on newer versions.
There is a possibility of a model for how the disease could be tracked. The one in 1918 that killed 50 million people was a flu epidemic. The public is encouraged to get their flu shots every year due to the seasonal flu outbreak.
Each year, health agencies including the World Health Organization make an educated guess as to which flu strains are most likely to circulate in the Northern Hemisphere's upcoming flu season. The vaccine production starts based on the flu strains.
The vaccine isn't always a good match with the strains that end up circulating most widely. The shot isn't as effective at preventing illness in those years. The flu vaccine field has been helped by a concerted international effort by public health agencies to prepare.
I think the COVID-19 field should think about adopting a similar system in the long term because of the differences between the particulars for the flu and the CoV-2 viruses. Researchers will be able to update the vaccine to match up-to-date coronaviruses if they stay on top of what's circulating.
As it spreads from person to person, it faces an evolutionary dilemma. While changing in ways that allow it to evade vaccine immunity, the virus needs to be able to get into human cells. The higher the chance that the vaccine will be useless against the new variant, the more it is designed to get your body to recognize a spikeProtein.
SARS-CoV-2 and its variant have evolved to be more transmissible and to better evade people's immune responses. Every four to seven months a new variant of concern has emerged and dominated transmission in a series of waves.
The D614G variant emerged in the spring of 2020 and became the new strain of the outbreak. The alpha variant dominated transmission over the course of two years. The alpha variant was displaced by the omicron variant at the end of the year.
There is no reason to believe that this trend will stop. The world may see a descendant of the various omicron subvariants in the near future. There is a chance that a new variant will emerge from a nondominant pool.
The current booster shots are based on the strain of the vaccine that has been extinct. It doesn't bode well for continued vaccine efficacy if the coronaviruses variant have changed a lot from the original one. The idea of yearly shots is appealing. Scientists don't yet know what the next variant of the disease will be.
The omicron subvariants currently circulating may look different in the fall and winter season. Better protection will likely be offered by an updated booster that resembles today's omicron subvariants and the immunity people already have from the first vaccines. At least as long as omicron sublineages continue to dominate, it might not need as much boosting.
The FDA is going to meet in the coming weeks to decide what the fall boosters should be. Moderna is currently testing their booster candidates in people and evaluating the immune response against new variant. The results of the test will determine what will be used.
It is possible to change the vaccine booster strategy to include universal coronaviruses vaccine approaches. A universal vaccine, which would be effective against multiple strains, is being worked on by researchers.
The idea of chimeric spikes is to combine parts of the spike of different coronaviruses together in a vaccine. The most vulnerable parts of the coronaviruses spike are the ones that the immune system focuses on.
In lab experiments, these strategies were shown to ward off the difficult-to-stop SARS-coV-2 variant. They work against both the original and zoonotic coronaviruses that could cause a future outbreak of the disease.
Multiple safe and effective vaccines have been provided by science. It is possible to steer us out of the COVID-19 Pandemic by changing booster strategies.
The University of North Carolina at Chapel Hill has a post-doc named David R.Martinez.
Under a Creative Commons license, this article is re-posted. The original article is worth a read.
All Rights Reserved © 2024
